The BD Insyte™ Autoguard™ Blood Control IV Catheter is a sterile, single-use peripheral intravenous catheter designed to support vascular access while incorporating Blood Control Technology and a passive needle shielding mechanism. The integrated blood control feature is designed to minimise blood exposure during catheter insertion, while the automatic needle shielding system helps reduce the risk of needlestick injury following needle withdrawal. Suitable for peripheral intravenous therapy in accordance with institutional protocols and clinical practice.
Key Features and Benefits:
- Blood Control Technology: Designed to reduce blood exposure during catheter insertion.
- Passive Safety Mechanism: Automatically shields the introducer needle following withdrawal to assist in reducing needlestick injury risk.
- 22G Catheter: Suitable for peripheral intravenous access where a 22-gauge catheter is clinically indicated.
- Radiopaque Catheter Material: Supports catheter visualisation if required.
- Sterile Single-Use Device: Individually packaged to support infection prevention practices.
- Integrated Safety Design: Combines blood control technology with automatic needle shielding in a single device.
- Clinical Applications: Suitable for peripheral intravenous therapy in hospitals, emergency departments, day surgery and other healthcare settings.
Specifications:
- Brand: BD
- Manufacturer: Becton, Dickinson and Company (BD)
- Product: BD Insyte™ Autoguard™ Blood Control IV Catheter (381023)
- Product Type: Peripheral Intravenous Safety Catheter
- Gauge: 22G
- Catheter Size: 0.9mm × 25mm (1")
- Colour: Blue
- Technology: Blood Control Technology
- Safety Feature: Passive automatic needle shielding
- Sterility: Sterile
- Single Use: Yes
- Latex: Latex Free
- Unit of Measure: Each
- Bulk Unit: 200 per Carton
- Image is a sample of product
Warning: Always read the label and follow directions for use.
The BD Insyte™ Autoguard™ Blood Control IV Catheter is a sterile, single-use peripheral intravenous catheter designed to support vascular access while incorporating Blood Control Technology and a pass...